Annual report
6894.TEDINET S100TR65
Period2023-04-01 → 2024-03-31
Filed2024-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥358m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥302m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥387m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥333m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥352m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥192m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥365m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥426m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥332m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥327m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥243m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥340m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥157m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥220m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥327m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥243m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥5.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥4.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥4.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.8bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.9bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥999m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥399m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥105m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥659m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥646m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥47m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥89m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥24m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥66m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥28m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥67m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥146m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥226m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥72m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥55m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥214m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥238.99 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.53 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248.75 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.4 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥160.51 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,685.76 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,497.84 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,392.34 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,188.43 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,126.2 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 70.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.9% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 128 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 134 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 134 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 136 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 134 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥351m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥297m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥377m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥328m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥342m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥190m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥364m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥416m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥328m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥319m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥241m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥331m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥154m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥220m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥4.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.6bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.3bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.0bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.9bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥232.87 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥175.86 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.58 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.58 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥160.93 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥110 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,658.93 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,484.83 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,385.25 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,192.91 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,133.15 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,393,459 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 127 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 133 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 133 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 135 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 133 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Healthcare Related Productsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Healthcare Related Productsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥8m |
| Healthcare Related Productsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥901m |
| Healthcare Related Productsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥901m |
| Healthcare Related Productsreportable segment | segment assets | at 2024-03-31 | ¥471m |
| Healthcare Related Productsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥43m |
| Optical Applications And Special Customized Productsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Optical Applications And Special Customized Productsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥11m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥819m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥819m |
| Optical Applications And Special Customized Productsreportable segment | segment assets | at 2024-03-31 | ¥507m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥259m |
| X Ray Residual Stress Analyzerreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥5m |
| X Ray Residual Stress Analyzerreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥891m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥891m |
| X Ray Residual Stress Analyzerreportable segment | segment assets | at 2024-03-31 | ¥479m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥384m |
| —segment total | employees | at 2024-03-31 | 113 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥10m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥33m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥686m |
| Healthcare Related Productsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1m |
| Healthcare Related Productsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥8m |
| Healthcare Related Productsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥998m |
| Healthcare Related Productsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥998m |
| Healthcare Related Productsreportable segment | segment assets | at 2023-03-31 | ¥590m |
| Healthcare Related Productsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥125m |
| Optical Applications And Special Customized Productsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥2m |
| Optical Applications And Special Customized Productsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥11m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥796m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥796m |
| Optical Applications And Special Customized Productsreportable segment | segment assets | at 2023-03-31 | ¥480m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥258m |
| X Ray Residual Stress Analyzerreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥9m |
| X Ray Residual Stress Analyzerreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥17m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥654m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥654m |
| X Ray Residual Stress Analyzerreportable segment | segment assets | at 2023-03-31 | ¥428m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥211m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥13m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥35m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥594m |
| —segment total | employees | at 2024-03-31 | 112 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,268
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 25200 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1353400 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 13534 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 14859 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 1393459 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 13534 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 25200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 25200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0181 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 25200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 25200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0181 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 150508000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 110.00 | |
| Number of male directors and other officers | FilingDateInstant | 8 | |
| Number of female directors and other officers | FilingDateInstant | － | |
| Ratio of female directors and other officers | FilingDateInstant | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000SuzukiYukihiroMember | 33140 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000AonoYoshiyukiMember | 15200 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000KudoTakashiMember | 6900 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000NishijimaNaokiMember | 800 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000TakagaiRyoMember | 3000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000SuzukiShigetoshiMember | 600 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000KatadaNaokiMember | 500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02021-000OkamotoEijiMember | 500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 60640 | |
| Audit fees reporting company | Prior1YearDuration | 17000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 17000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 17000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 17000000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 90990000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 78570000 | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 12420000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 5 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 10800000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 10800000 | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 1 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |